2 recruiting, 1 not yet recruiting. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Radionecrosis of Brain: new trials by email Literature Review of Radionecrosis of Brain trials Research Report on Radionecrosis of Brain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases Bevacizumab, Placebo, Prednisolone - Radionecrosis of Brain, Brain Metastases | Phase 3 | Recruiting | Institut Cancerologie de l'Ouest | 84 | 2025-04-29 | 2025-08-17 |
| FET-PET-Guided Management of Pseudoprogression in Glioblastoma Clinical management based on the index MRI and an additional [¹⁸F] FET PET scan - Glioblastoma, Radionecrosis of Brain | Not applicable | Not yet recruiting | Veerle Ruijters | 144 | 2024-08-01 | 2024-06-28 |
| A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma Chlorophyllin - Diffuse Glioma, Radionecrosis of Brain | Phase 2 | Recruiting | Tata Memorial Centre | 118 | 2023-11-13 | 2025-04-11 |
Glioblastoma (2) · Brain Neoplasms (1) · Disease Progression (1) · Glioma (1)
Neoplasms (3) · Astrocytoma (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Neuroepithelial (2) · Neuroectodermal Tumors (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Disease Attributes (1) · Glioma (1) · Neoplasms by Site (1) · Nervous System Diseases (1)
Adrenal Cortex Hormones (1) · Bevacizumab (1) · Prednisolone (1) · chlorophyllin (1)
Institut Cancerologie de l'Ouest (1) · Tata Memorial Centre (1) · Veerle Ruijters (1)
France (1) · India (1) · Netherlands (1)
Archya Dasgupta, MD (1) · Luc Ollivier, MD (1) · Nelleke Tolboom, MD, PhD (1) · Tom J Snijders, MD, PhD (1)